ROBERT L REID M.D. NPI 1790753325

NPI Details

Robert L Reid, M.D. is a hematology and oncology internal medicine in Fairfax, VA. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Robert L Reid, M.D. NPI is 1790753325. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

8613 LEE HWY # 200N
FAIRFAX, VA
ZIP 22031-171
Phone: (703) 208-3155
Fax: (703) 280-9596

The NPI 1790753325 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, pemetrexed, not otherwise specified, 10 mg (HCPCS:J9305)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Nephelometry, test method using light (HCPCS:83883)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Protein measurement, serum (HCPCS:84165)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Unclassified drugs (HCPCS:J3490)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Folic acid level, serum (HCPCS:82746)
• Uric acid level, blood (HCPCS:84550)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Magnesium level (HCPCS:83735)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Refilling and maintenance of portable pump (HCPCS:96521)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)

The enumeration date for this NPI number is 3/9/2006 and was last updated on 10/24/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.